Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics
Abstract Preoperative renal tumor subtype differentiation is important for radiology and urology in clinical practice. Pharmacokinetic data (K trans & V e, etc.) derived from dynamic contrast-enhanced MRI (DCE-MRI) have been used to investigate tumor vessel permeability. In this prospective stud...
Guardado en:
Autores principales: | Hai-yi Wang, Zi-hua Su, Xiao Xu, Ning Huang, Zhi-peng Sun, Ying-wei Wang, Lu Li, Ai-tao Guo, Xin Chen, Xin Ma, Lin Ma, Hui-yi Ye |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa27053d5f964a738b5cd351a1f8710c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Suitability of pharmacokinetic models for dynamic contrast-enhanced MRI of abdominal aortic aneurysm vessel wall: a comparison.
por: V Lai Nguyen, et al.
Publicado: (2013) -
Quantitative estimation of renal function with dynamic contrast-enhanced MRI using a modified two-compartment model.
por: Bin Chen, et al.
Publicado: (2014) -
Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent
por: Hedgire SS, et al.
Publicado: (2014) -
Assessment of single-vessel cerebral blood velocity by phase contrast fMRI.
por: Xuming Chen, et al.
Publicado: (2021) -
Artificially controlled degradable nanoparticles for contrast switch MRI and programmed cancer therapy
por: Yun T, et al.
Publicado: (2018)